2 completed, 1 terminated. 2 Phase 1, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Terminated 1 |
Follow Midatech Pharma US Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CED of MTX110 Newly Diagnosed Diffuse Midline Gliomas Infusate with MTX110 and gadolinium, Convection-Enhanced Delivery (CED) - Diffuse Intrinsic Pontine Glioma, Diffuse Pontine and Thalamic Gliomas | Phase 1 | Completed | Luca Szalontay | 9 | 2020-03-10 | 2023-12-18 |
| MTX110 by Convection-Enhanced Delivery in Treating Participants With Newly-Diagnosed Diffuse Intrinsic Pontine Glioma Panobinostat Nanoparticle Formulation MTX110, Convection-Enhanced Delivery (CED) - Diffuse Intrinsic Pontine Glioma | Phase 1 / Phase 2 | Completed | Sabine Mueller, MD, PhD | 7 | 2018-05-22 | 2022-02-25 |
| Gelclair at Conditioning or After Oral Mucositis Diagnosed vs. Magic Mouth Wash in Stem Cell Transplant Recipients Gelclair, First® Mouthwash BLM - Oral Mucositis | Phase 4 | Terminated | Midatech Pharma US Inc. | 28 | 2018-05-15 | 2019-11-22 |
Diffuse Intrinsic Pontine Glioma (2) · Stomatitis (1)
Gadolinium (1)
United States (3)
Luca Szalontay, MD (1) · Mary Kay Delmedico, PhD (1) · Sabine Mueller, M.D. (1)